![Cancers | Free Full-Text | Comparison of Four Validated Nomograms (Memorial Sloan Kettering Cancer Center, Briganti 2012, 2017, and 2019) Predicting Lymph Node Invasion in Patients with High-Risk Prostate Cancer Candidates for Cancers | Free Full-Text | Comparison of Four Validated Nomograms (Memorial Sloan Kettering Cancer Center, Briganti 2012, 2017, and 2019) Predicting Lymph Node Invasion in Patients with High-Risk Prostate Cancer Candidates for](https://pub.mdpi-res.com/cancers/cancers-15-01683/article_deploy/html/images/cancers-15-01683-g002.png?1678363603)
Cancers | Free Full-Text | Comparison of Four Validated Nomograms (Memorial Sloan Kettering Cancer Center, Briganti 2012, 2017, and 2019) Predicting Lymph Node Invasion in Patients with High-Risk Prostate Cancer Candidates for
![External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients | SpringerLink External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00345-020-03322-9/MediaObjects/345_2020_3322_Fig1_HTML.png)
External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients | SpringerLink
![External validation of the 2019 Briganti nomogram for the identification of PCa patients who should be considered for an ePLND - UROONCO Prostate Cancer External validation of the 2019 Briganti nomogram for the identification of PCa patients who should be considered for an ePLND - UROONCO Prostate Cancer](https://prostate.uroonco.uroweb.org/wp-content/uploads/sites/9/External-Validation-of-the-2019-Briganti-Nomogram.jpg)
External validation of the 2019 Briganti nomogram for the identification of PCa patients who should be considered for an ePLND - UROONCO Prostate Cancer
![External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection - European Urology External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection - European Urology](https://www.europeanurology.com/cms/asset/6d032d3d-3bc4-4199-9d78-e36556b20a5b/gr1.jpg)
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection - European Urology
![External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients | SpringerLink External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00345-020-03322-9/MediaObjects/345_2020_3322_Fig4_HTML.png)
External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients | SpringerLink
![PDF) Beyond the Briganti nomogram: Individualisation of lymphadenectomy using selective sentinel node biopsy during radical prostatectomy for prostate cancer PDF) Beyond the Briganti nomogram: Individualisation of lymphadenectomy using selective sentinel node biopsy during radical prostatectomy for prostate cancer](https://i1.rgstatic.net/publication/311464166_Beyond_the_Briganti_nomogram_Individualisation_of_lymphadenectomy_using_selective_sentinel_node_biopsy_during_radical_prostatectomy_for_prostate_cancer/links/5acb19460f7e9bcd5198d54d/largepreview.png)